Nomura Micro Science (6254) Q3 2025 earnings summary

Executive summary

• Net sales for the nine months ended December 31, 2024, were ¥31,855 million, down 48.0% year-over-year, with operating profit at ¥3,933 million, down 53.5% year-over-year.

• Profit attributable to owners of parent was ¥2,066 million, a 64.4% decrease year-over-year.

• Orders received dropped 65.6% year-over-year to ¥17,634 million, reflecting regional variation and the completion of large-scale projects.

• The company is executing its medium-term management plan, focusing on profitability, capital efficiency, financial optimization, and sustainability.

Financial highlights

• Gross profit for the period was ¥8,198 million, with comprehensive income at ¥2,372 million, down 61.8% year-over-year.

• Basic earnings per share for the period was ¥54.91, calculated post-share split.

• Total assets increased to ¥100,351 million from ¥70,602 million at the previous fiscal year-end.

• Net assets rose slightly to ¥29,334 million, with an equity-to-asset ratio of 28.7%.

Outlook and guidance

• Full-year forecast for FY2025 remains unchanged: net sales ¥96,000 million (+31.5% YoY), operating profit ¥14,300 million (+34.3% YoY), profit attributable to owners of parent ¥9,650 million (+21.0% YoY), and basic EPS ¥256.28.

• Annual dividend forecast is ¥70.00 per share post-share split.